Here, we describe the reciprocal regulation of a kinase, the microtubule affinity-regulating kinase 2 (MARK2), and an acetyltransferase, CREB-binding protein (CBP), two enzymes known to extensively modify tau proteins in the progression of Alzheimer’s disease. This evidence concerns the gene MARK2 and early-onset autosomal dominant Alzheimer disease.